Related Experiment Videos
Sulfisomidine in the treatment of pertussis
Insights
Sulfisomidine treatment for pertussis in infants showed promising results, with no fatalities observed in 21 patients. Effective drug concentrations were achieved, and adverse effects were minimal.
Area of Science:
- Pediatrics
- Infectious Diseases
- Pharmacology
Background:
- Pertussis (whooping cough) is a serious bacterial infection, particularly in infants.
- Limited treatment options exist for severe pertussis cases, especially in young children.
Purpose of the Study:
- To evaluate the efficacy and safety of sulfisomidine in treating pertussis.
- To determine appropriate therapeutic drug concentrations and assess patient outcomes.
Main Methods:
- A cohort of 21 pertussis patients, primarily infants under six months, received sulfisomidine and pertussis serum.
- Drug dosages were administered at 0.26 gm/kg/24 hours, with blood concentrations monitored.
- Patient outcomes, including hospital stay and adverse events, were recorded.
Main Results:
- Therapeutic blood concentrations of sulfisomidine were achieved in 14 out of 21 patients.
- The average hospital stay was 10 days.
- No patient deaths occurred; one case of hematuria resolved with increased fluid intake.
Conclusions:
- Sulfisomidine, in combination with pertussis serum, appears to be an effective treatment for pertussis, particularly in young infants.
- The drug is generally well-tolerated, with minimal adverse effects observed.
- Further research may explore optimal dosing and long-term outcomes.
Abstract:
Sulfisomidine and pertussis serum were used in the treatment of 21 patients with pertussis. Twenty of the patients were under six months of age and seven had bronchopneumonia. Therapeutic concentrations of the drug in the blood were obtained in 14 cases when it was given in dosage of 0.26 gm. per kilogram of body weight per 24 hours. The average stay in hospital was ten days. None of the patients died. Hematuria developed in one case but crystalluria was not concomitant and it abated promptly when fluid intake was increased.